Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05839756
Other study ID # Post Extubation Stridor
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 3, 2023
Est. completion date June 30, 2025

Study information

Verified date February 2024
Source Mansoura University
Contact Maha A AboZeid, MD
Phone 02-01019216192
Email mahazed@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Endotracheal intubation can induce laryngotracheal injury which results in narrowing of the airway due to edema of the glottis. This can increase the risk of development of post-extubation stridor (PES)


Description:

Ultrasound (US) is a useful and non-invasive tool for the evaluation of vocal cords and laryngeal morphology in intubated patients. The laryngeal air-column width (LACW), Laryngeal air column width difference (LACWD), and laryngeal air-column width ratio (LACWR) measured by ultrasound can potentially identify patients at risk of post-extubation stridor, in whom caution should be taken after extubation. The cuff-leak test can predict successful extubation through using the difference between the expired tidal volume with the cuff inflated and with the cuff deflated; the higher the leak, the lower the likelihood that post-extubation stridor will occur.


Recruitment information / eligibility

Status Recruiting
Enrollment 62
Est. completion date June 30, 2025
Est. primary completion date February 25, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patients (>18 years) - American Society of Anesthesiologists status I and II - undergoing elective maxillomandibular fixation surgeries under general anesthesia with nasal endotracheal intubation Exclusion Criteria: - patients' refusal - pregnant females - patients with body mass index <18.5 or = 35 kg/m2 - risk of aspiration - cardiorespiratory disorder - neuromuscular disease - uncontrolled diabetes mellitus - gastrointestinal bleeding - on chronic steroid therapy - intubated patients or were intubated or had upper airway infection within 1 week prior to surgery - history of any pathology, radiotherapy or surgery in the neck - had difficult laryngeal US plane (as neck wound)

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
budesonide
2 ml nebulized budesonide (containing 1 mg) diluted in 3 ml of normal saline will be nebulized preoperatively
normal saline
5 ml normal saline will be nebulized preoperatively

Locations

Country Name City State
Egypt Maha Ahmed AboZeid Mansoura

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Other Expiratory tidal volume immediate after intubation with the cuff deflated ml immediately after intubation
Other Expiratory tidal volume immediate before extubation with the cuff inflated ml immediately before extubation
Other Expiratory tidal volume immediate before extubation with the cuff deflated ml immediately before extubation
Other cuff leak volume ml immediate after intubation and immediate before extubation
Other Laryngeal air column width mm before intubation
Other Laryngeal air column width mm immediate after intubation during the balloon-cuff inflation and during balloon-cuff deflation
Other Laryngeal air column width mm immediate before extubation during the balloon-cuff inflation and during balloon-cuff deflation
Other Laryngeal air column width difference mm immediate after intubation and immediate before extubation
Other incidence of postoperative sore throat, dysphonia, swallowing disorders or PES. 4-point verbal descriptor scale (0=no symptoms, 1=mild, 2=moderate, 3=severe) First postoperative day
Primary Laryngeal air column width ratio immediately before extubation
Secondary The duration of nasal endotracheal intubation min Procedure (from nasal endotracheal intubation till extubation)
Secondary endotracheal tube insertion depth cm immediately after intubation
Secondary The incidence of epistasis occurrence during nasotracheal intubation 4-point verbal descriptor scale (0=no symptoms, 1=mild, 2=moderate, 3=severe) immediately after intubation
Secondary Expiratory tidal volume immediate after intubation with the cuff inflated ml immediately after intubation
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02244697 - The Yield of Laryngeal Ultrasound in the Evaluation of Stridor and Dysphonia in Children N/A
Recruiting NCT06144398 - Single Use Flexible Bronchoscopes in Interventional Pulmonary Procedures N/A
Not yet recruiting NCT02056379 - Comparison Between Budesonide and Dexamethasone Treatments for Respiratory Discomfort After Extubation on Children N/A
Completed NCT02523820 - Nebulized Corticosteroid for Post Extubation Stridor in Children Phase 3
Withdrawn NCT02700087 - In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms? N/A
Not yet recruiting NCT01991964 - The Yield of Laryngeal Ultrasound in the Diagnosis of Laryngomalacia N/A
Recruiting NCT06212037 - POCUS of the Pediatric Critical Airway